I
Idorsia Pharmaceuticals Ltd
| Research |
OneLook
Acronym Finder
|
| Serial Number | 79351483 |
| Mark Drawing Code | 5000: Illustration: Drawing with word(s)/letter(s)/number(s) in Stylized form |
Timeline
| 2022-09-06 | Application Filed |
| 2022-09-29 | Location: INITIAL REVIEW/SERIALIZATION BRANCH(MAILROOM) |
| 2022-09-29 | Status: Live/Pending |
| 2022-09-30 | Transaction Date |
Trademark Applicants & Owners
| Owner: |  Idorsia Pharmaceuticals Ltd |
| Address | Hegenheimermattweg 91 CH-4123 Allschwil CH |
| Legal Entity Type | Aktiengesellschaft (ag) |
| Legal Entity State | CH |
Documents
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
Attorney of Record
Good, Services, and Codes
| International Codes: | 5 |
| U.S. Codes: | 005,006,018,044,046,051,052 |
| Type Code | Type |
|---|---|
| GS0051 | Pharmaceutical preparations for prevention or treatment of cardiovascular diseases, hypertension, vasospasms associated with aneurysmal subarachnoid hemorrhage, kidney diseases, pulmonary diseases, fibrotic diseases, cystic fibrosis, inflammatory diseases, allergic diseases, autoimmune diseases and disorders, neurodegenerative diseases, neurological disorders, diseases and disorders of the central nervous system, dementia, insomnia, anxiety disorders, drug addiction, eating disorders, epilepsy, metabolic disorders, diabetes, glycolipid storage disorders, Fabry disease and symptoms and sequelae of Fabry disease, infectious diseases and cancer |
Trademark Filing History
| Description | Date | Event Coding |
|---|---|---|
| SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB | 2022-09-29 | 1 SDRC M: |
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2022-09-30 | 2 NWOS I:Incoming Correspondence |
| APPLICATION FILING RECEIPT MAILED | 2022-10-04 | 3 MAFR O:Outgoing Correspondence |
| ASSIGNED TO EXAMINER | 2023-04-20 | 4 DOCK D:Assigned to Examiner |
| NON-FINAL ACTION WRITTEN | 2023-04-21 | 5 CNRT R:Renewal |
| NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | 2023-04-22 | 6 RFCR E:E-Mail |
| REFUSAL PROCESSED BY MPU | 2023-06-08 | 7 RFRR P: |
| NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | 2023-06-08 | 8 RFCS P: |
| REFUSAL PROCESSED BY IB | 2023-07-03 | 9 RFNT P: |
| ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | 2023-12-22 | 10 ABN2 O:Outgoing Correspondence |
| ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND | 2023-12-22 | 11 MAB2 O:Outgoing Correspondence |
| ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND | 2023-12-22 | 12 MAB2 O:Outgoing Correspondence |
| NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | 2024-03-06 | 13 OPNR P: |
| NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | 2024-03-06 | 14 OPNS P: |
| NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | 2024-03-25 | 15 OPNX P: |
Similar Marks
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 